![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » JAPAN'S TAISHO ENDS DIABETES DRUG TIE-UP WITH LILLY
JAPAN'S TAISHO ENDS DIABETES DRUG TIE-UP WITH LILLY
August 7, 2006
Japanese drug maker Taisho Pharmaceutical Co. said on Monday it has ended a development tie-up with Eli Lilly and Co. on its diabetes drug and will continue its development on its own.
Yahoo News (http://asia.news.yahoo.com/060807/3/2o4ia.html)
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
21Oct